查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1746890

日本神經調節市場報告（按技術、生物材料、應用和地區）2025-2033

Japan Neuromodulation Market Report by Technology, Biomaterial, Application, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 121 Pages | 商品交期: 5-7個工作天內

價格
簡介目錄

2024年，日本神經調節市場規模達3.492億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到10.298億美元，2025-2033年期間的複合年成長率（CAGR）為12.8%。日本老齡人口的不斷成長、近期的技術進步、醫療支出的不斷增加、人們對神經調節益處的認知不斷提高、主要市場參與者的強勁表現以及優惠報銷政策的訂定，是推動市場發展的一些關鍵因素。

神經調節是一種透過將藥物或電促效劑傳送到神經系統目標區域來改變神經活動的技術。它涵蓋多種類型，包括脊髓刺激、深部腦部刺激、薦神經刺激和周邊神經刺激。神經調節由多個組件組成，例如脈衝產生器、電極和用於編程的手持設備。它具有多種功能，包括微創手術、可自訂的治療設定和即時回饋機制。神經調節廣泛用於治療慢性疼痛、癲癇、運動障礙、精神疾病、偏頭痛和胃腸道疾病。它提供標靶治療，與全身給藥相比副作用較小、可逆性強，並具有遠端患者監測的潛力。此外，神經調節還具有多種優勢，例如增強患者依從性、提高生活品質、長期成本效益以及即時調整治療設定的機會。

日本神經調節市場趨勢：

日本老齡人口不斷成長，導致神經系統疾病和慢性疾病發病率不斷上升，這推動了市場的成長。此外，近期的技術進步，例如無線神經調節技術的出現，正在拓展該技術的應用範圍，也推動了市場的成長。此外，醫療支出的增加和神經病學研究的優先化，為市場擴張創造了有利的環境，也是另一個促進成長的因素。此外，人們對神經調節益處的認知不斷提高，從而促進了神經調節技術的更快應用，這正在催化市場的成長。此外，日本主要市場參與者的強大影響力和頻繁的產品發布也刺激了市場的成長。此外，政府醫療體系為神經調節手術引入的優惠報銷政策也促進了市場的成長。此外，越來越多的臨床試驗證據表明神經調節技術有效，進一步增強了該技術的可信度，對市場成長產生了積極的影響。同時，對微創手術的廣泛需求推動了神經調節應用的發展，從而支撐了市場的成長。同時，神經調節領域熟練醫療專業人員數量的不斷成長也推動了市場的成長。此外，人工智慧 (AI) 的即時調整和監控也為市場成長創造了積極的前景。此外，患者對神經調節的依從性和滿意度不斷提高，鼓勵了更多轉診，加速了市場的成長。此外，主要參與者之間為擴大研究範圍並利用共享專業知識而不斷增加的策略合作和收購，也正在增強市場的成長。此外，公共和私人部門對研發 (R&D) 活動的投資不斷增加，也推動了市場的成長。

日本神經調節市場細分：

技術洞察：

  • 內部神經調節
    • 脊髓刺激（SCS）
    • 深部腦部刺激（DBS）
    • 迷走神經刺激（VNS）
    • 薦神經刺激（SNS）
    • 胃電刺激（GES）
  • 外部神經調節
    • 經皮神經電刺激（TENS）
    • 經顱磁刺激（TMS）
    • 其他

生物材料見解：

  • 金屬生物材料
  • 聚合物生物材料
  • 陶瓷生物材料

應用程式洞察：

  • 帕金森氏症
  • 癲癇
  • 沮喪
  • 肌張力失調
  • 疼痛管理
  • 其他

競爭格局：

市場研究報告也對市場競爭格局進行了全面分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭指標和公司評估象限等競爭分析。此外，報告還提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

  • 日本神經調節市場迄今表現如何？未來幾年將如何表現？
  • COVID-19 對日本神經調節市場有何影響？
  • 日本神經調節市場依技術如何分類？
  • 日本神經調節市場根據生物材料的分佈是怎麼樣的？
  • 日本神經調節市場根據應用如何分類？
  • 日本神經調節市場的價值鏈分為哪些階段？
  • 日本神經調節的主要促進因素和挑戰是什麼？
  • 日本神經調節市場的結構是怎麼樣的？主要參與者是誰？
  • 日本神經調節市場的競爭程度如何？

本報告回答的關鍵問題：

  • 日本神經調節市場迄今表現如何？未來幾年將如何表現？
  • COVID-19 對日本神經調節市場有何影響？
  • 日本神經調節市場依技術如何分類？
  • 日本神經調節市場根據生物材料的分佈是怎麼樣的？
  • 日本神經調節市場根據應用如何分類？
  • 日本神經調節市場的價值鏈分為哪些階段？
  • 日本神經調節的主要促進因素和挑戰是什麼？
  • 日本神經調節市場的結構是怎麼樣的？主要參與者是誰？
  • 日本神經調節市場的競爭程度如何？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：日本神經調節市場 - 簡介

  • 概述
  • 市場動態
  • 產業趨勢
  • 競爭情報

第5章：日本神經調節市場格局

  • 歷史與當前市場趨勢（2019-2024）
  • 市場預測（2025-2033）

第6章：日本神經調節市場-細分：依技術

  • 內部神經調節
    • 概述
    • 市場區隔
      • 脊髓刺激（SCS）
      • 深部腦部刺激（DBS）
      • 迷走神經刺激（VNS）
      • 薦神經刺激（SNS）
      • 胃電刺激（GES）
  • 外部神經調節
    • 概述
    • 市場區隔
      • 經皮神經電刺激（TENS）
      • 經顱磁刺激（TMS）
      • 其他

第7章：日本神經調節市場-細分：依生物材料

  • 金屬生物材料
    • 概述
  • 聚合物生物材料
    • 概述
  • 陶瓷生物材料
    • 概述

第 8 章：日本神經調節市場 - 細分：按應用

  • 帕金森氏症
    • 概述
  • 癲癇
    • 概述
  • 沮喪
    • 概述
  • 肌張力失調
    • 概述
  • 疼痛管理
    • 概述
  • 其他

第9章：日本神經調節市場-競爭格局

  • 概述
  • 市場結構
  • 市場參與者定位
  • 最佳獲勝策略
  • 競爭儀錶板
  • 公司評估象限

第10章：關鍵參與者簡介

  • Company A
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company B
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company C
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company D
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events
  • Company E
    • Business Overview
    • Services Offered
    • Business Strategies
    • SWOT Analysis
    • Major News and Events

第 11 章：日本神經調節市場 - 產業分析

  • 促進因素、限制因素和機遇
    • 概述
    • 驅動程式
    • 限制
    • 機會
  • 波特五力分析
    • 概述
    • 買家的議價能力
    • 供應商的議價能力
    • 競爭程度
    • 新進入者的威脅
    • 替代品的威脅
  • 價值鏈分析

第 12 章：附錄

簡介目錄
Product Code: SR112025A19378

Japan neuromodulation market size reached USD 349.2 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,029.8 Million by 2033, exhibiting a growth rate (CAGR) of 12.8% during 2025-2033. The rising geriatric population in Japan, recent technological advancements, increasing healthcare expenditure, heightened awareness about the benefits of neuromodulation, strong presence of key market players, and introduction of favorable reimbursement policies represent some of the key factors driving the market.

Neuromodulation refers to a technology involving the modification of nerve activity by delivering pharmaceutical or electrical agents to targeted areas of the nervous system. It encompasses a wide range of types, including spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, and peripheral nerve stimulation. Neuromodulation is comprised of several components, such as a pulse generator, electrodes, and a handheld device for programming. It offers multiple features, including minimally invasive procedures, customizable treatment settings, and real-time feedback mechanisms. Neuromodulation is widely used for treating chronic pain, epilepsy, movement disorders, psychiatric conditions, migraines, and gastrointestinal issues. It offers targeted therapy, reduced side effects as compared to systemic drug administration, reversibility, and the potential for remote patient monitoring. Additionally, neuromodulation provides several advantages, such as enhanced patient compliance, better quality of life, cost-effectiveness in the long run, and the opportunity for real-time adjustments to treatment settings.

Japan Neuromodulation Market Trends:

The rising geriatric population in Japan, contributing to the escalating incidences of neurological and chronic disorders, is propelling the market growth. Additionally, recent technological advancements, such as the advent of wireless neuromodulation, that are expanding the technique's applications are driving the market growth. Besides this, the increasing healthcare spending and the prioritization of neurological research, fostering a conducive environment for market expansion, is acting as another growth-inducing factor. Furthermore, the heightened awareness about the benefits of neuromodulation, which is facilitating faster adoption rates, is catalyzing the market growth. In addition to this, the strong presence of key market players and frequent product launches in Japan is stimulating the market growth. Apart from this, the introduction of favorable reimbursement policies by the government healthcare system for neuromodulation procedures is bolstering the market growth. Moreover, the growing evidence of the efficacy of neuromodulation through clinical trials, lending further credence to the technology, is positively influencing the market growth. Along with this, the widespread demand for minimally invasive procedures, boosting neuromodulation applications, is supporting the market growth. In line with this, the escalating number of skilled healthcare professionals in the field of neuromodulation is driving the market growth. Furthermore, the integration of artificial intelligence (AI) for real-time adjustments and monitoring is creating a positive outlook for the market growth. In addition, the rising patient compliance and satisfaction rates with neuromodulation, encouraging more referrals, is accelerating the market growth. Besides this, the increasing strategic collaborations and acquisitions among key players to expand further research and leverage shared expertise are strengthening the market growth. Additionally, the growing public and private investment in research and development (R&D) activities is fueling the market growth.

Japan Neuromodulation Market Segmentation:

Technology Insights:

  • Internal Neuromodulation
    • Spinal Cord Stimulation (SCS)
    • Deep Brain Stimulation (DBS)
    • Vagus Nerve Stimulation (VNS)
    • Sacral Nerve Stimulation (SNS)
    • Gastric Electrical Stimulation (GES)
  • External Neuromodulation
    • Transcutaneous Electrical Nerve Stimulation (TENS)
    • Transcranial Magnetic Stimulation (TMS)
    • Others

Biomaterial Insights:

  • Metallic Biomaterials
  • Polymeric Biomaterials
  • Ceramic Biomaterials

Application Insights:

  • Parkinson's Disease
  • Epilepsy
  • Depression
  • Dystonia
  • Pain Management
  • Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan neuromodulation market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan neuromodulation market?
  • What is the breakup of the Japan neuromodulation market on the basis of technology?
  • What is the breakup of the Japan neuromodulation market on the basis of biomaterial?
  • What is the breakup of the Japan neuromodulation market on the basis of application?
  • What are the various stages in the value chain of the Japan neuromodulation market?
  • What are the key driving factors and challenges in the Japan neuromodulation?
  • What is the structure of the Japan neuromodulation market and who are the key players?
  • What is the degree of competition in the Japan neuromodulation market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Neuromodulation Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Neuromodulation Market Landscape

  • 5.1 Historical and Current Market Trends (2019-2024)
  • 5.2 Market Forecast (2025-2033)

6 Japan Neuromodulation Market - Breakup by Technology

  • 6.1 Internal Neuromodulation
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2019-2024)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 Spinal Cord Stimulation (SCS)
      • 6.1.3.2 Deep Brain Stimulation (DBS)
      • 6.1.3.3 Vagus Nerve Stimulation (VNS)
      • 6.1.3.4 Sacral Nerve Stimulation (SNS)
      • 6.1.3.5 Gastric Electrical Stimulation (GES)
    • 6.1.4 Market Forecast (2025-2033)
  • 6.2 External Neuromodulation
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2019-2024)
    • 6.2.3 Market Segmentation
      • 6.2.3.1 Transcutaneous Electrical Nerve Stimulation (TENS)
      • 6.2.3.2 Transcranial Magnetic Stimulation (TMS)
      • 6.2.3.3 Others
    • 6.2.4 Market Forecast (2025-2033)

7 Japan Neuromodulation Market - Breakup by Biomaterial

  • 7.1 Metallic Biomaterials
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2019-2024)
    • 7.1.3 Market Forecast (2025-2033)
  • 7.2 Polymeric Biomaterials
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2019-2024)
    • 7.2.3 Market Forecast (2025-2033)
  • 7.3 Ceramic Biomaterials
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2019-2024)
    • 7.3.3 Market Forecast (2025-2033)

8 Japan Neuromodulation Market - Breakup by Application

  • 8.1 Parkinson's Disease
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2019-2024)
    • 8.1.3 Market Forecast (2025-2033)
  • 8.2 Epilepsy
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2019-2024)
    • 8.2.3 Market Forecast (2025-2033)
  • 8.3 Depression
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2019-2024)
    • 8.3.3 Market Forecast (2025-2033)
  • 8.4 Dystonia
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2019-2024)
    • 8.4.3 Market Forecast (2025-2033)
  • 8.5 Pain Management
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2019-2024)
    • 8.5.3 Market Forecast (2025-2033)
  • 8.6 Others
    • 8.6.1 Historical and Current Market Trends (2019-2024)
    • 8.6.2 Market Forecast (2025-2033)

9 Japan Neuromodulation Market - Competitive Landscape

  • 9.1 Overview
  • 9.2 Market Structure
  • 9.3 Market Player Positioning
  • 9.4 Top Winning Strategies
  • 9.5 Competitive Dashboard
  • 9.6 Company Evaluation Quadrant

10 Profiles of Key Players

  • 10.1 Company A
    • 10.1.1 Business Overview
    • 10.1.2 Services Offered
    • 10.1.3 Business Strategies
    • 10.1.4 SWOT Analysis
    • 10.1.5 Major News and Events
  • 10.2 Company B
    • 10.2.1 Business Overview
    • 10.2.2 Services Offered
    • 10.2.3 Business Strategies
    • 10.2.4 SWOT Analysis
    • 10.2.5 Major News and Events
  • 10.3 Company C
    • 10.3.1 Business Overview
    • 10.3.2 Services Offered
    • 10.3.3 Business Strategies
    • 10.3.4 SWOT Analysis
    • 10.3.5 Major News and Events
  • 10.4 Company D
    • 10.4.1 Business Overview
    • 10.4.2 Services Offered
    • 10.4.3 Business Strategies
    • 10.4.4 SWOT Analysis
    • 10.4.5 Major News and Events
  • 10.5 Company E
    • 10.5.1 Business Overview
    • 10.5.2 Services Offered
    • 10.5.3 Business Strategies
    • 10.5.4 SWOT Analysis
    • 10.5.5 Major News and Events

11 Japan Neuromodulation Market - Industry Analysis

  • 11.1 Drivers, Restraints, and Opportunities
    • 11.1.1 Overview
    • 11.1.2 Drivers
    • 11.1.3 Restraints
    • 11.1.4 Opportunities
  • 11.2 Porters Five Forces Analysis
    • 11.2.1 Overview
    • 11.2.2 Bargaining Power of Buyers
    • 11.2.3 Bargaining Power of Suppliers
    • 11.2.4 Degree of Competition
    • 11.2.5 Threat of New Entrants
    • 11.2.6 Threat of Substitutes
  • 11.3 Value Chain Analysis

12 Appendix